The Principal investigator, MD Hanne Thürmer for the multicentre trial «RituxME» at Dept. of Medicine Notodden, Telemark Hospital, held a presentation with regard to current insights and experience at 8feb2016. The report performed by the blogsite «ME-foreldrene«is now available on english.
RituxME is a multicentre Medical treatment trial conducted in five study centres in Norway: the Oncology Department at Haukeland University Hospital, the ME/CFS Centre at Oslo University Hospital (Aker), the Dept of Medicine at Notodden Hospital, the Dept. of Pain and Complex Disorders at St. Olav’s Hospital in Trondheim, and the Division of Rehabilitation Services at the University Hospital of North Norway in Tromsø.
Still talking about: A randomised, double-blind and placebo controlled phase III study with Rituximab induction and maintenance treatment in patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis, as defined by the Canadian Consensus Criteria (2003).
You can find and read the report from the event here:
Lecture by dr Hanne Thürmer, Notodden Hospital Original in Norwegian/Norsk original From a lecture given at the local department of the Norwegian ME-association in Notodden, avd Telemark, Norway, F…
Read report her: Lecture by Hanne Thürmer, Notodden. RituxME and current development